Your browser doesn't support javascript.
loading
Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
Zeissig, Sebastian; Petersen, Britt-Sabina; Tomczak, Michal; Melum, Espen; Huc-Claustre, Emilie; Dougan, Stephanie K; Laerdahl, Jon K; Stade, Björn; Forster, Michael; Schreiber, Stefan; Weir, Dascha; Leichtner, Alan M; Franke, Andre; Blumberg, Richard S.
Afiliación
  • Zeissig S; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Kiel, Germany Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Petersen BS; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Tomczak M; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Melum E; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway K.G.
  • Huc-Claustre E; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Kiel, Germany.
  • Dougan SK; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Laerdahl JK; Department of Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway Bioinformatics Core Facility, Department of Informatics, University of Oslo, Oslo, Norway.
  • Stade B; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Forster M; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Schreiber S; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Kiel, Germany Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Weir D; Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Leichtner AM; Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Blumberg RS; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gut ; 64(12): 1889-97, 2015 Dec.
Article en En | MEDLINE | ID: mdl-25367873
ABSTRACT

OBJECTIVE:

IBD is a group of complex, systemic disorders associated with intestinal inflammation and extraintestinal manifestations. Recent studies revealed Mendelian forms of IBD, which contributed significantly to our understanding of disease pathogenesis and the heritability of IBD.

DESIGN:

We performed exome sequencing in a family with Crohn's disease (CD) and severe autoimmunity, analysed immune cell phenotype and function in affected and non-affected individuals, and performed in silico and in vitro analyses of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) structure and function.

RESULTS:

A novel missense variant was identified in CTLA4 encoding CTLA-4, a coinhibitory protein expressed by T cells and required for regulation of T cell activation. The residue affected by the mutation, CTLA-4 Tyr60, is evolutionarily highly conserved, and the identified Y60C variant is predicted to affect protein folding and structural stability and demonstrated to cause impaired CTLA-4 dimerisation and CD80 binding. Intestinal inflammation and autoimmunity in carriers of CTLA-4 Y60C exhibit incomplete penetrance with a spectrum of clinical presentations ranging from asymptomatic carrier status to fatal autoimmunity and intestinal inflammation. In a clinically affected CTLA-4 Y60C carrier, T cell proliferation was increased in vitro and associated with an increased ratio of memory to naive T cells in vivo, consistent with impaired regulation of T cell activation.

CONCLUSIONS:

Our results support the concept that variants in CTLA4 provide the basis for a novel Mendelian form of early-onset CD associated with systemic autoimmunity. Incomplete penetrance of autoimmunity further indicates the presence of other genetic and/or environmental modifiers.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfocitos T Citotóxicos / Enfermedad de Crohn / Autoinmunidad / Antígeno CTLA-4 Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfocitos T Citotóxicos / Enfermedad de Crohn / Autoinmunidad / Antígeno CTLA-4 Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos